Physician profile
Stephanie Schaefer
NPI 1003228776
$4,032.08
in general payments reported to CMS, 2019-2025
30 companies · $670 in 2025
The $670 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $64.76 · 2021: $292 · 2022: $319 · 2023: $497 · 2024: $1,974 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,842 · Travel and Lodging: $1,258 · Education: $40.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,842.21 |
| Travel and Lodging | $1,258.10 |
| Education | $40.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,648.28 | 2023-2024 | Axonics, Bulkamid |
| Abbvie INC. | $330.44 | 2019-2024 | Liletta |
| Mayne Pharma Commercial LLC | $325.58 | 2021-2025 | Bijuva |
| Evofem Biosciences, INC. | $259.84 | 2021-2025 | Phexxi, Solosec, Phexx |
| Boston Scientific Corporation | $174.07 | 2025 | Axonics |
| Shield Therapeutics INC | $159.29 | 2023-2025 | Accrufer |
| Astellas Pharma US INC | $114.13 | 2022-2025 | Veozah, Myrbetriq |
| Applied Medical Resources Corporation | $112.51 | 2024 | Gelpoint V-Path |
| Becton, Dickinson and Company | $111.15 | 2021-2025 | Arista |
| Intuitive Surgical, INC. | $99.17 | 2023 | Da Vinci Surgical System |
| Millicent US INC | $95.84 | 2019-2025 | Intrarosa, Femring |
| Biogen, INC. | $88.14 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $59.00 | 2022-2024 | Paragard T 380a |
| Avion Pharmaceuticals | $51.03 | 2020-2021 | |
| Organon LLC | $47.43 | 2022-2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $44.23 | 2021-2022 | |
| Scynexis, INC. | $37.42 | 2022 | |
| Pfizer INC. | $32.65 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $31.55 | 2024 | Gemtesa |
| Hologic Sales and Service, LLC | $31.22 | 2021 | |
| Baxter Healthcare | $28.94 | 2022 | |
| Lupin INC. | $23.66 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $17.70 | 2021 | |
| Duchesnay USA Incorporated | $17.54 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.17 | 2021 | |
| Meditrina | $16.70 | 2022 | |
| Tactile Systems Technology INC | $16.53 | 2025 | Flexitouch Plus, Nimbl |
| Covidien LP | $14.57 | 2019 | |
| Aspira Women'S Health INC | $13.48 | 2024 | Ova1 |
| Therapeuticsmd, INC. | $12.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Schaefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.